GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $988,000 | -0.2% | 22,711 | -0.1% | 0.01% | +20.0% |
| Q1 2022 | $990,000 | -9.4% | 22,736 | -8.3% | 0.01% | 0.0% |
| Q4 2021 | $1,093,000 | +10.1% | 24,802 | -4.6% | 0.01% | 0.0% |
| Q3 2021 | $993,000 | -24.9% | 26,002 | -21.7% | 0.01% | -16.7% |
| Q2 2021 | $1,322,000 | -2.4% | 33,202 | -12.6% | 0.01% | -14.3% |
| Q1 2021 | $1,355,000 | -36.8% | 37,986 | -34.8% | 0.01% | -36.4% |
| Q4 2020 | $2,144,000 | -29.6% | 58,281 | -28.0% | 0.01% | -38.9% |
| Q3 2020 | $3,047,000 | -12.2% | 80,976 | -4.9% | 0.02% | -18.2% |
| Q2 2020 | $3,472,000 | -17.7% | 85,131 | -23.6% | 0.02% | -29.0% |
| Q1 2020 | $4,220,000 | -21.7% | 111,401 | -2.9% | 0.03% | +6.9% |
| Q4 2019 | $5,392,000 | +2.0% | 114,751 | -7.4% | 0.03% | -3.3% |
| Q3 2019 | $5,287,000 | -1.1% | 123,895 | -7.3% | 0.03% | -6.2% |
| Q2 2019 | $5,347,000 | -25.7% | 133,610 | -22.5% | 0.03% | -28.9% |
| Q1 2019 | $7,201,000 | -9.2% | 172,333 | -17.0% | 0.04% | -18.2% |
| Q4 2018 | $7,931,000 | -9.6% | 207,573 | -7.6% | 0.06% | +1.9% |
| Q3 2018 | $8,778,000 | -21.8% | 224,738 | -19.3% | 0.05% | -19.4% |
| Q2 2018 | $11,224,000 | -5.4% | 278,443 | -8.3% | 0.07% | -9.5% |
| Q1 2018 | $11,862,000 | -12.7% | 303,633 | -20.7% | 0.07% | -6.3% |
| Q4 2017 | $13,586,000 | -59.4% | 383,030 | -53.5% | 0.08% | -60.7% |
| Q3 2017 | $33,462,000 | -8.0% | 824,206 | -2.3% | 0.20% | -12.6% |
| Q2 2017 | $36,375,000 | -1.5% | 843,578 | -3.7% | 0.23% | -1.7% |
| Q1 2017 | $36,937,000 | +3.8% | 876,115 | -5.1% | 0.23% | +2.6% |
| Q4 2016 | $35,569,000 | -1.1% | 923,631 | +10.8% | 0.23% | -5.8% |
| Q3 2016 | $35,957,000 | +2.3% | 833,699 | +2.8% | 0.24% | -0.8% |
| Q2 2016 | $35,137,000 | +12.1% | 810,733 | +4.9% | 0.24% | +11.4% |
| Q1 2016 | $31,346,000 | +5.4% | 773,021 | +4.9% | 0.22% | -3.1% |
| Q4 2015 | $29,727,000 | +5.4% | 736,748 | +0.5% | 0.23% | +6.6% |
| Q3 2015 | $28,194,000 | +4.7% | 733,283 | +13.4% | 0.21% | +15.2% |
| Q2 2015 | $26,941,000 | +28.7% | 646,864 | +42.6% | 0.18% | +31.4% |
| Q1 2015 | $20,939,000 | +27.0% | 453,719 | +17.6% | 0.14% | +37.3% |
| Q4 2014 | $16,492,000 | +0.2% | 385,873 | +7.8% | 0.10% | +3.0% |
| Q3 2014 | $16,457,000 | -18.4% | 358,009 | -5.1% | 0.10% | -12.4% |
| Q2 2014 | $20,165,000 | +0.9% | 377,053 | +0.8% | 0.11% | -2.6% |
| Q1 2014 | $19,986,000 | +3.2% | 374,067 | +3.1% | 0.12% | +6.4% |
| Q4 2013 | $19,366,000 | +8.6% | 362,728 | +2.0% | 0.11% | +4.8% |
| Q3 2013 | $17,836,000 | +7.1% | 355,512 | +6.6% | 0.10% | +3.0% |
| Q2 2013 | $16,659,000 | – | 333,390 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |